ABSTRACT: Long-chain omega-3 PUFA (LC n-3 PUFA) are beneficial for health. To date there is no specific food frequency questionnaire (FFQ) to assess LC n-3 PUFA intakes. The objective of this study is to validate our newly developed FFQ by comparison with LC n-3 PUFA content of both red blood cells (RBC) and plasma, expressed as a percentage of total FA. Fifty-three healthy male and female subjects were recruited from Wollongong, Australia. Average LC n-3 PUFA intakes (mg/d) were estimated using the new FFQ. RBC and plasma FA were assessed using GC. Spearman correlation coefficients were used to assess the linear relationship between FFQ intakes and both RBC and plasma FA. The results show that there were significant Spearman's correlation coefficients between the FFQ intakes and RBC (and plasma) FA for total LC n-3 PUFA, EPA, and DHA (0.50 (0.54), 0.39 (0.54) and 0.40 (0.48), respectively) but not for docosapentaenoic acid. The FFQ was also an effective ranking tool. The FFQ is a valid method based on erythrocyte and plasma FA as biochemical markers. In conclusion, the new FFQ is a valid method that can be used to estimate the LC n-3 PUFA intake of adults.
The various health benefits of consuming the long-chain n-3 PUFA (LC n-3 PUFA), particularly EPA and DHA, have been reported widely (1) (2) (3) (4) (5) (6) . The LC n-3 PUFA are obtained predominately from fish, seafood, meat, and eggs (7, 8) and in recent years from enriched food products such as bread, milk, margarine, and eggs. Recommendations for dietary intakes of LC n-3 PUFA vary considerably from the consumption of two fish meals a week (9) to EPA plus DHA intakes of 500 mg/d (10); the Japanese recommend consumption of LC n-3 PUFA of 1.6 g/d (11) .
Currently there is no tailor-made food frequency questionnaire (FFQ) to assess LC n-3 PUFA intakes. We have developed a new FFQ that estimates the dietary intakes of LC n-3 PUFA. The FFQ was found to be highly reproducible and valid compared with 3-d weighed food records in 53 healthy adults (12) . However, as biochemical measurements of specific nutrients in the blood or other tissues can also provide useful assessments of nutrient intake (13) , it is desirable to validate the FFQ further using biomarkers of LC n-3 PUFA intake.
There are several choices of a biomarker for the measurement of LC n-3 PUFA, including FA in adipose tissue (14) , red blood cells (RBC), platelets, plasma, cholesterol esters, phospholipids (13) , and potentially cheek cells (15) . RBC may be a useful marker as they can provide an indication of the previous 120 d intake of LC n-3 PUFA, the approximate lifespan of a single RBC (16) . RBC were found to be a good biomarker of LC n-3 PUFA intake as EPA and DHA were incorporated into RBC according to dose (17) . Plasma has also been found to reflect LC n-3 PUFA intake in various studies (18, 19) .
The aims of this study were to (1) compare estimates of dietary LC n-3 PUFA intakes using the new FFQ with previously published results; (2) compare estimates of dietary LC n-3 PUFA intakes using the new FFQ with RBC FA; (3) compare estimates of dietary LC n-3 PUFA intakes with plasma FA; and (4) determine the efficacy of the FFQ to rank individuals into quintiles of intakes of LC n-3 PUFA by comparison with quintiles of RBC and plasma FA.
MATERIALS AND METHODS

Subject recruitment and clinic visits.
Poster and e-mail advertisements were used to recruit staff and students from the University of Wollongong, Australia. There were no exclusion criteria, and the only requirement was that subjects had maintained a constant diet over the previous 3 mon. Vegetarians were encouraged to volunteer to ensure a wide range of dietary habits among the subjects. Based on RBC data from a previously unpublished study, it was determined that a minimum of 50 subjects should be sufficient to detect an effect size of 1 with more than 99% power at a significance level of 0.05, assuming that the correlation between methods is 0.6. The effect size is the difference between the means of the two methods, divided by the SD of either method.
Subjects attended a single clinic appointment and came in after an overnight fast to provide a fasted blood sample for RBC and plasma FA analysis. Digital scales and a wallmounted stadiometer were used to measure weights and heights, respectively. Subjects then completed the FFQ. Approval to conduct the study was obtained from the University of Wollongong Human Research Ethics Committee, and subjects gave their written consent.
LC n-3 PUFA FFQ and determination of intakes. The 28-item semi-quantitative FFQ consists of a list of food items that are currently the only major contributors to LC n-3 PUFA intake. The foods included in the 28 questions are from the following food groups: fish and seafood (6 questions), meats (12) , cereals (4), fat spreads (2), dairy (2), and eggs (2), including LC n-3 PUFA-fortified products such as breads, milks, margarines, and eggs. Fish oil capsules are also included in the questionnaire. The FFQ also asks the subject to estimate usual meat serving size in terms of pictures of meat servings on a plate. The dietary validation of this FFQ has been published elsewhere (12) . The FFQ was self-administered by subjects and took approximately 15 min to complete. The LC n-3 PUFA intakes of FFQ and the 3-d weighed Food Record (FR) were determined as described by Sullivan et al. (12) .
Comparison with other published intakes. To determine whether the FFQ is measuring a plausible intake, another dietary intake comparator was necessary. Therefore, the intakes estimated using the FFQ were compared with those of a larger Australian sample using a 24-h recall method taken from the 1995 National Nutrition Survey (NNS) to estimate LC n-3 PUFA intake (20) . The NNS collected data from 10,591 Australians aged 19 years and older, but at a time when omega-3 fortified foods were not on the market. The Wilcoxon signed rank test was used to compare the FFQ data (without the inclusion of fortified foods or fish oil capsules) to the 3-d weighed food record (FR) as previously described (12) with comparison with the NNS data (21) .
Blood collection and preparation and analysis of RBC and plasma FA. Blood was collected into tubes containing EDTA and placed on ice. The samples were separated by centrifugation (10 min, 3,000 rpm, 4°C). The plasma was separated from the sample into labeled eppendorf tubes. The white buffy layer was removed and discarded, and the remaining RBC were transferred into labeled eppendorf tubes. RBC and plasma samples were stored at -80°C until analyzed.
RBC membranes were prepared for FA analysis as described by Ridges et al. (22) . The total volume of the resuspended pellets was transferred into glass tubes for direct transesterification as described by Lepage and Roy (23) . Briefly, 2 mL of methanol:toluene (4:1) was added to each sample. While vortexing, 200 µL of acetyl chloride was added dropwise to each sample using a positive displacement pipette. Samples were then heated for 60 min at 100°C in a heating block. After the tubes had been cooled in cold water, 3 mL of potassium chloride (10%) and 100 µL of toluene were added to each tube before centrifugation for 10 min (3,000 rpm, 4°C). The FAME, contained in the upper toluene phase, were removed and placed into GC vials. The FAME were analysed by flame-ionization GC (model GC-17A, Shimadzu) using a 30 m × 0.25 mm i.d. capillary column. Individual FA were identified upon comparison with known FA standards (Supelco FAME mix C4-C24 (plus added DPA), #18919-1AMP, Sigma-Aldrich, Castle Hill, Australia).
Total plasma FA were determined using the method of Lepage and Roy (23) . Aliquots of 200 µL of plasma were transferred into glass tubes for direct transesterification (23) as briefly described above; however, instead of using 3 mL potassium chloride (10%), 5 mL potassium chloride (5%) was used, and instead of adding 100 µL toluene, no toluene was added. FAME were analyzed as described above.
Comparison of FFQ and LCn-3 PUFA content of RBC and plasma. Means (SD) were calculated for the total LCn-3 PUFA, EPA, docosapentaenoic acid (DPA), and DHA content (as a percentage of total FA) of the RBC and plasma. Spearman's correlation coefficients were determined for the relationship between FFQ estimated daily intakes and LCn-3 PUFA content of both RBC and plasma.
Quintile agreement. Subjects were ranked in ascending order of their daily total intake of LC n-3 PUFA estimated from the FFQ and both RBC and plasma FA. They were then separated into quintiles. Quintiles were determined by assessing the actual intakes from 53 subjects ranging from 0 to 1,100 mg/d and then dividing the subjects into 5 equal groups, where quintile 1 equals 0-98 mg/d, quintile 2 equals 99-188 mg/d, quintile 3 equals 189-304 mg/d, quintile 4 equals 305-449 mg/d, and quintile 5 equals 450-1,100 mg/d. The percentage agreement was determined between the quintile assignments using the FFQ and RBC FA, and separately for the FFQ and plasma FA.
Statistical analysis. Means (SD) were calculated for the total LCn-3 PUFA, EPA, DPA, and DHA content (as a percentage of total FA) of the RBC and plasma. The relationships between FFQ estimated daily intakes and LCn-3 PUFA content of both RBC and plasma were assessed by Spearman's correlation coefficients.
Quintile agreement was assessed by determining the percentage agreement between quintile assignments using the FFQ and RBC FA and for FFQ and plasma FA.
Statistical analysis was performed using JMP statistical analysis program (version 5.1, SAS Institute, Cary, NC). Statistical significance was set at α = 0.05 for all analyses.
RESULTS
Fifty-three subjects (20 male and 33 female) were recruited for the validity study, including seven self-reported vegetarians. Two vegetarians were vegans, one ate extremely small amounts of fish, and two were lactoovovegetarians. The remaining two reported eating significant amounts of fish in the FFQ. The subject characteristics are presented in Table 1 .
Comparison of our FFQ LC n-3 PUFA intakes with the NNS of Australia. Table 2 shows the LC n-3 PUFA intake data estimated from the FFQ (excluding fortified foods and fish oil capsules) in comparison with the analysis of the NNS of Australia conducted by Howe et al. (20) . There were no significant differences between the estimates in this study using the FFQ and the NNS data.
Comparison of our LC n-3 PUFA FFQ with the FA content of RBC and plasma. Comparison of the LC n-3 PUFA intakes estimated from the FFQ with the percentage of the total FA content of RBC and plasma is shown in Table 3 .
Bivariate plots of the FFQ estimation of LC n-3 PUFA intakes and percentage of total FA content of the RBC showed that there were good, significant relationships for total LC n-3 PUFA, EPA, and DHA (Figs. 1a, 1b, and 1d) . There was no apparent relationship for DPA (Fig. 1c) . Similar patterns were ob-served for the relationship between the FFQ estimated intakes and LC n-3 PUFA content of plasma. As seen with the RBC, there was no relationship between FFQ estimation of DPA intakes and the content of plasma as indicated by the non-significant Spearman's correlation of 0.09.
The efficacy of the FFQ to rank individuals into quintiles of intakes of LC n-3 PUFA. Subjects were also assigned quintiles based on total LC n-3 PUFA content of the RBC (% of total FA) ( Table 4 ). Forty percent of subjects were correctly assigned into the same quintiles, and 75% of subjects were assigned to either the same or adjacent quintile. The FFQ was most successful at identifying individuals with very low intakes. Similar results were obtained for agreement of quintile assignment between FFQ total LC n-3 PUFA intakes and total LC n-3 PUFA content of plasma (Table 4) . Five out of the seven vegetarian subjects were found in the first quintile for both analyses.
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DISCUSSION
Our new FFQ estimates the dietary intakes of LC n-3 PUFA very well as the results compare favorably with the results from the NNS of Australia (Table 2 , and ref. 20) . The NNS intakes of EPA and DPA were slightly higher and the NNS intakes of DHA were slightly lower than in our study, which could be explained by the fact that our study group contained seven vegetarians. With meat being a rich source of DPA (24), the inclusion of seven vegetarian subjects (who did not eat meat) in this study may account for the lower DPA intakes.
Other studies have used various biomarkers to validate newly developed or existing FFQ, although not many have been validated for LC n-3 PUFA intake, and those that do use biomarkers other than RBC. Woods et al. (25) validated an existing semiquantitative FFQ for measuring fish intake with plasma FA composition. That FFQ was assessing overall dietary intake over the preceding 12 mon and was originally de 21 (40) 19 (36) 13 (24) 15 (28) 26 (49) 12 (23) for DHA and 0.34 for total LC n-3 PUFA). Significant Pearson correlation coefficients were also obtained between the percentage of total plasma n-3 PUFA and the same two variables (both 0.33). Our FFQ shows higher Spearman's correlation coefficients (r = 0.50 for total LC n-3 PUFA, r = 0.39 for EPA, and r = 0.40 for DHA), hence our newly developed FFQ is an improvement on previously validated FFQ to estimate LC n-3 PUFA intakes (25) .
There are a few reasons why our new FFQ shows higher correlations. First, in Woods et al. (25) , intakes of fish (steamed, baked, grilled, fried, and takeaway fish) and tinned fish were calculated without the inclusion of other types of seafood. There was no distinction between different fish species, which are known to have large variations in LC n-3 PUFA content (24) . Second, other foods that contain LC n-3 PUFA, such as eggs and meat, were not included in the analysis (8) , and these may account for nearly 50% of LC n-3 PUFA intakes (20) . Finally, a major limitation was that at the time of the study there was no Australian database for the estimation of DHA and EPA intakes from the FFQ, which has now been rectified by Mann et al. (26) .
Our correlation coefficients between RBC and dietary intakes of LC n-3 PUFA compare favorably with the study by Anderson et al. (18) . Correlation coefficients between plasma phospholipid FA and dietary intakes of EPA and DHA were 0.51 and 0.49, respectively. Their correlation between fish intake and n-3 PUFA in plasma phospholipids was 0.37, whereas our correlation coefficient of total intake of LC n-3 PUFA and RBC LC n-3 PUFA was 0.5. Their lower correlation between fish intake and n-3 PUFA in plasma phospholipids further highlights the fact that foods other than fish and seafood contribute to LC n-3 PUFA intake (20) .
The mean percentages of LC n-3 PUFA in RBC in our study were comparable to those determined in other studies (17, 26) . LC n-3 PUFA content of plasma was, however, lower than reported in other studies (25, 27) . RBC and plasma were found to be good biomarkers of total LC n-3 PUFA, EPA, and DHA intakes as highlighted by the significant Spearman's correlation coefficients, but RBC and plasma were not found to be good biomarkers of DPA intakes (r = 0.05). Significant correlations between dietary intakes and RBC FA were expected for EPA and DHA as both FA have been found to be incorporated into RBC by dose (17) . However, DPA intakes estimated from the FFQ were found to be highly reproducible with a highly significant Spearman's correlation coefficient of 0.89 (12) . This evidence strongly suggests that the lack of correlation is not due to the FFQ instrument itself and that it is more likely due to biological or metabolic factors and this warrants further investigation.
Quintile assignment proved that the FFQ was able to adequately identify individuals according to their RBC levels of LC n-3 PUFA. Five out of the seven vegetarians were correctly assigned to the first (lowest intake) quintile based on intakes measured by the FFQ and LC n-3 content of the RBC. Agren et al. (28) also found that Finnish vegans had significantly lower EPA, DPA, and DHA in their RBC than omnivorous subjects. The other two self-reported vegetarians, as expected, had higher LC n-3 PUFA content of RBC due to significant intakes of fish and seafood. Overall, the quintile assignment in this study was better than or consistent with other studies. The FFQ used by Erkkola et al. (29) classified 62% of individuals into the same or adjacent quintiles based on total n-3 PUFA intakes. The ability of this FFQ to classify more than 75% of individuals into identical or adjacent quintiles may be useful in clinical settings to identify individuals with low LC n-3 PUFA status.
In summary, the FFQ performed well against the RBC membrane and total plasma FA, apart from the lack of correlation between DPA intakes and DPA content of both RBC and plasma, suggesting that these may not be good biomarkers of DPA intake. The FFQ is therefore an adequate dietary assessment tool for the estimation of total LC n-3 intakes in healthy Australian adults and would be a useful screening tool for low intakes of LC n-3 PUFA. It is an appealing alternative to other dietary assessment methods due to its validity, low subject burden and low cost, and being very fast to complete. In conclusion, the FFQ is a valid dietary assessment tool for the estimation of dietary LC n-3 PUFA.
